Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Organix is a premier contract research organization (CRO) specializing in high-end organic synthesis and drug discovery services. Founded in 1986 by former Arthur D. Little scientists, the company provides expertise in the synthesis of complex small molecules, including lipids for drug delivery, carbohydrates, and stable isotopes. Organix serves a global clientele ranging from virtual biotech startups to major pharmaceutical corporations, offering custom synthesis, process development, and medicinal chemistry support. The company is particularly recognized for its proficiency in lipid chemistry, supporting the development of lipid nanoparticles (LNPs) for mRNA and genomic medicine delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Organix Chemistry Solutions.